Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target

March 21, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×470-biogen.jpg" NAME"Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target" ALT"Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target"March 22, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId…
Source: BioSpace

Posted in BioPharma